Objective: Inflammation may play a pathogenic role in chronic heart failure (CHF). The objective of the study was to characterise the imbalance in the cytokine network in CHF. Methods: cDNA expression arrays were used to analyse the gene expression of cytokines and related mediators in peripheral blood mononuclear cells (PBMC) from CHF patients (n58) and healthy controls (n58). Real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) was used to determine the gene expression of individual genes in additional 12 patients and eight controls. Results: From 375 genes, 34 were upregulated and two downregulated in CHF patients in the cDNA expression array experiments. Regulated genes included chemokines / -receptors, members of the transforming growth factor b superfamily, orphan receptors and in particular several members of the tumor necrosis factor (TNF) superfamily. Thus, 4-1BB ligand (L), APRIL, CD27L, CD40L, FasL, LIGHT, TRAIL-receptor 4 were upregulated, while TRAIL-receptor 3 was downregulated. Real-time quantitative RT-PCR confirmed significantly upregulated gene expression of APRIL, LIGHT, FasL and CD27L in CHF patients and showed in addition significantly enhanced gene expression of TNFa and TRAIL. Conclusion: The present study demonstrates differential gene expression in PBMC of several members of the cytokine network in CHF. In particular, the enhanced expression of several ligands in the TNF superfamily may reflect a potential pathogenic role of these cytokines in CHF.
Introduction
dysfunction and fibrosis in both in vitro and in vivo models [4] [5] [6] . For example, cardiac-specific overexpression of Persistent inflammation may play a pathogenic role in TNFa, as well as infusion of TNFa, even in concentrations the progression of chronic heart failure (CHF). Thus, comparable to those found in the circulation during CHF, several clinical studies have reported elevated circulating have been reported to cause a dilated cardiomyopathy-like levels of inflammatory cytokines, such as tumor necrosis phenotype mimicking several aspects of clinical heart factor (TNF)a, interleukin (IL)-6 and IL-1 in CHF in failure, indicating that both circulating and locally prodirect relation to the clinical severity of the disease [1] [2] [3] .
duced cytokines may induce myocardial dysfunction [7, 8] . Additionally, inflammatory cytokines have been shown to While several reports have demonstrated enhanced induce events characterising the remodelling process durplasma levels of inflammatory cytokines in CHF patients ing CHF, including cardiomyocyte hypertrophy, contractile [3] , few studies have examined these mediators in circulating leukocytes [9] [10] [11] . Circulating inflammatory cells may not only contribute to the systemic immune activation in 2.2. Isolation of PBMC these patients, but may also, by infiltrating the failing myocardium, indirectly promote myocardial dysfunction PBMC were obtained from heparinised blood by Iso- [12] . Moreover, while much attention have been drawn to paque-Ficoll (Lymphoprep, Nycomed Pharma AS, Oslo, TNFa and IL-6 in CHF, our knowledge of other members Norway) gradient centrifugation within 45 min as previof the cytokine network is limited. For example, whereas ously described [14] . Cell pellets were stored in liquid there is strong evidence for TNFa as a pathogenic factor in nitrogen until used. CHF [13] , other members of the TNF superfamily may potentially be even more important, but these mediators 2.3. cDNA expression array hybridisation have hardly been studied in this disorder.
1
Our objective was to further characterise the imbalance Poly-A -RNA was isolated for cDNA expression array in the cytokine network in CHF. In the present study we experiments using the Dynabeads mRNA DIRECT Kit used a cDNA array based approach to analyse the gene (Dynal, Oslo, Norway) as recommended by the manufac- 6 expression of a large number of cytokines and other turer. Briefly, |5310 frozen PBMC from each individual 1 inflammatory mediators in peripheral blood mononuclear were lysed in Lysis / binding buffer, poly-A -RNA was cells (PBMC) from CHF patients and healthy blood hybridised to Dynabeads Oligo(dT) and subsequently 25 1 donors. washed before elution in nuclease-free water. Poly-A -RNA was quantified using spectrophotometry (OD260 / 280 nm) and stored at 280 8C until used. Two pools of 1 |500 ng poly-A RNA were prepared from eight controls 2. Methods and eight CHF patients to represent the mean gene 33 expression in the two populations. P-labeled cDNA was 2.1. Patients subsequently prepared using the cDNA Labeling and Hybridisation Kit (R&D Systems, Minneapolis, MN). Twenty patients with stable CHF for .6 months in Unincorporated nucleotides were removed using Probe-NYHA functional class II-III were studied (Table 1) . We Quant G-50 columns (Amersham Pharmacia Biotech, did not include end-stage CHF patients (i.e. NYHA class Piscataway, NJ). Hybridisation to Human Cytokine Ex-IV) in our study to, if possible, avoid that our findings pression Arrays (R&D Systems) and washing were permerely reflect cachexia or severe hemodynamic dearrangeformed using conditions described by the manufacturer. ment. None of the patients had any evidence of myocardial
The array was exposed to a phosphor screen for 1 and 4 infarction or unstable angina during the past 6 months and days and scanned using Cyclone System (Packard, none had significant concomitant disease such as infection, Meriden, CT). Individual hybridisation signals were idenor connective tissue disease. Control subjects were 16 tified and quantitated densitometrically using Phoretix healthy age and sex-matched blood donors (Table 1 ). The Array (Nonlinear dynamics, Newcastle, UK) and normalinvestigation conforms with the principles outlined in the ised to the glyceraldehyde 3-phosphate dehydrogenase Declaration of Helsinki.
(GAPDH) mRNA signal. The normalised hybridisation signals for the CHF group were subsequently divided to 280 8C. None of the samples showed any signs of DNA the corresponding signals for the control group. A gene contamination using PCR with intron-specific primers for was considered to be upregulated when the ratio CHF to GAPDH. Sequence specific PCR primers and TaqMan control exceeded 2.0 and considered to be downregulated probes were designed using the Primer Express software when the ratio was below 0.5 as recommended by the version 1.5 (Applied Biosystems, Foster City, CA), see manufacturer. The cDNA expression array included sever- Table 2 for details. Quantification of mRNA was peral 'housekeeping genes' and we found only minor changes formed using the ABI Prism 7700 (Applied Biosystems). in the expression of these genes when using GAPDH as Reverse transcription (RT) was performed using TaqMan control gene in the array analysis. For example, the ratio Reverse Transcription reagents (Applied Biosystems). Each CHF / blood donor for b-actin, cyclophilin A, a-tubulin and RT-reaction contained 100 ng total RNA, 5 ml 103 RT transferrin receptor, representing other common control Buffer, 2.5 ml 50 mM Random Hexamers, 1.25 ml MultiSgenes, was 1.26, 1.21, 0.91 and 1.19, respectively. Based cribe Reverse Transcriptase (50 U / ml), 1 ml RNase on these data, our use of GAPDH as control gene should Inhibitor (20U / ml), 11 ml 25 mM MgCl , 10 ml dNTP 2 be valid. Mixture and nuclease-free water made up to 50 ml. The reaction was incubated at 25 8C for 10 min, followed by 2. 4 Table 2 Characteristics of the real-time PCR assays used in the study
The table shows the sequence of primers and probes used in the real-time PCR assays and the corresponding amplicon size. (1), forward primers; (2), reverse primers; Acc.nr., accession number in GenBank; FAM, 6-carboxyfluorescein; TAMRA, carboxytetramethylrhodamine.
Each sample was run in triplicate. Cycling parameters were 3. Results 95 8C for 10 min followed by 40 cycles of 95 8C for 15 s and 60 8C for 1 min. Standard curves were run on the same 3.1. Identification of differentially expressed genes in plate and the relative standard curve method was used to PBMC calculate the relative gene expression as previously described [15] . GAPDH was included as an endogenous By using cDNA expression arrays, we analysed the gene normalisation control to adjust for unequal amounts of expression of 375 cytokines, cytokine receptors and related RNA.
mediators comparing PBMC from eight CHF patients and eight healthy blood donors. Radioactively labelled cDNA was prepared from pooled RNA from the two populations 2.5. Statistical analysis and hybridised to two array membranes. One hundred and forty-one genes were detected in PBMC from blood donors Statistical comparisons were performed using the compared to 208 genes in CHF patients. As described in Mann-Whitney rank sum test. P values were two-sided Table 3 , densitometric analysis revealed several differand considered significant when ,0.05.
ences between these two groups of individuals with (Fig. 1) . In in CHF patients and healthy controls. Thus, the expression addition we demonstrated increased mRNA levels of of the TNF superfamily ligands (L) 4-1BBL, APRIL (a TNFa (8.8-fold increase, P,0.001) and TRAIL (2.0-fold proliferation inducing ligand), CD27L, CD40L, FasL and increase, P,0.01) in the CHF group, while no significant LIGHT (homologous to lymphotoxins, inducible expreschanges in gene expression were found for CD30L, sion, competes with HSV glycoprotein D for HVEM lymphotoxin-b and TWEAK (Fig. 1 ). There were no [herpes virus entry mediator], a receptor expressed on Tdifferences in the gene expression of the TNF superfamily lymphocytes), in addition to the TNF-related apoptosis ligands comparing CHF patients with coronary artery inducing ligand (TRAIL) receptor (R) 4, were all upregudisease and dilated cardiomyopathy (data not shown). lated in the CHF group. In contrast, the decoy receptor Moreover, although there were differences in the medica-TRAIL R3 was markedly downregulated in these patients.
tion within the CHF group, we were not able to relate the Secondly, also several chemokines and chemokine redegree of gene expression of TNF superfamily ligands to ceptors were upregulated in CHF patients. Thus, both the use of any medication as presented in Table 1 . macrophage inflammatory protein (MIP)-1a and -1b as well as their corresponding receptor, CCR5, were markedly upregulated in CHF patients compared with healthy 4. Discussion controls. Finally, PBMC from CHF patients also showed enhanced expression of some genes in the transforming 4.1. Findings growth factor (TGF) b family, interferon (IFN)-a and -b and IFN-g inducing factor (i.e. IL-18) receptor genes as While increased levels of certain inflammatory cytokines well as genes for several orphan receptors (i.e., receptors (e.g. TNFa, IL-1 and IL-6) have been demonstrated in with unknown ligands)( Table 3 ). In fact, the gene expres-CHF [3] , few studies have examined the expression of sion of the orphan receptor Bob, possibly related to the these mediators at the cellular levels. Even more imchemokine family [16] , showed the most marked upregulaportantly, the imbalance in the cytokine network involving tion (7.4-fold increase) comparing PBMC from CHF a wide range of mediators is poorly characterised in this patients and healthy controls (Table 3) .
disorder. In our screening experiments, demonstrating for the first time a complex set of changes in the cytokine 3.2. Gene expression of TNF superfamily ligands network in PBMC during CHF by using cDNA expression arrays, we have pinpointed several potentially interesting A major finding in the cDNA expression array experigenes and gene families in the cytokine network that ment was the upregulation of several genes in the TNF should be further investigated for their possible pathogenic superfamily in PBMC from CHF patients. To further role in this disorder. In particular, we found a marked elucidate this finding we used real-time quantitative RTupregulation of several ligands in the TNF superfamily in PCR to determine the message levels of genes of ligands in PBMC from CHF patients as demonstrated by both cDNA the TNF superfamily in PBMC from another 12 CHF expression arrays and real-time quantitative RT-PCR methpatients and eight healthy blood donors. In this experiment ods. While the pathophysiological role of TNFa in CHF we examined both the gene expression of the six genes that has been extensively examined and several studies have were upregulated in the array experiment (i.e. 4-1BBL, reported raised TNFa levels in this disorder [13] , the APRIL, CD27L, CD40L, FasL and LIGHT) as well as the literature is virtually devoid of data concerning other gene expression of other detectable ligands in the TNF members of the TNF superfamily in human heart failure. superfamily, i.e. CD30L, lymphotoxin-b, TNFa, TRAIL Thus, except for some reports of altered Fas / FasL levels in and TWEAK (T NF-related ligand with weak ability to CHF [17, 18] , the present study is, to our knowledge, the induce cell death) with CHF / control ratios of 1.7, 1.0, 1.4, first demonstration of altered expression of several mem-1.6 and 1.7, respectively, in the cDNA array experiment.
bers of the TNF superfamily in CHF patients. This analysis was performed both to investigate the precision in the cDNA expression array experiment and to 4.2. Methodological considerations obtain a more complete and accurate picture of the regulation of this family of cytokines in CHF.
The accuracy and reproducibility of cDNA arrays have The real-time quantitative RT-PCR experiment conbeen widely discussed [19] . Our findings in the present firmed the differential gene expression in four out of the study underscore the need for confirmation of results from cDNA array experiments by additional and independent gene expression and extreme variations may also affect the methods. Thus, while we confirmed the upregulation of mean leading to false positives, particularly for low APRIL, CD27L, FasL and LIGHT by real-time quantitaabundance genes. tive RT-PCR, the upregulation of 4-1BBL and CD40L were not verified. Notably, for both 4-1BBL and CD40L 4.3. Potential pathological implications the hybridisation signals were low. Obviously, the quantification of low abundance transcripts will be vulnerable to Although the biological role of the TNF superfamily variations in background levels and sensitivity, in contrast ligands is still unclear, some of their known effects may be to the more abundant transcripts.
of interest in the context of CHF. Notably, receptors for Because our goal in the cDNA array experiments was to APRIL, FasL, LIGHT, TNFa and TRAIL have been identify genes that were markedly differentially expressed reported to be expressed in the heart [20] [21] [22] [23] [24] [25] [26] [27] , and it is in PBMC from CHF patients and controls, pooled mRNA therefore not inconceivable that ligand-receptor interacfrom the two groups of individuals was used. This tions involving these upregulated TNF superfamily ligprocedure has both advantages and obvious disadvantages.
ands, either soluble or bound to infiltrating leukocytes may On the one hand, analysis of pooled mRNA will reflect the represent potential pathogenic pathways in the progression mean in the two populations, reducing the signal noise of myocardial failure. For example, abnormal apoptosis is introduced by individual patient variation, being an accurrecognised as a potential pathogenic factor in the proate way to screen for markedly differentially expressed gression of myocardial failure [28] , and known deathgenes in a study population. On the other hand, the use of inducing ligands such as TNFa, FasL, TRAIL and LIGHT pooled mRNA can result in loss of interesting variation in [29] , that all were upregulated in CHF patients in the present study, may well be involved in this process. References However, recent reports suggest that myocardial over-
